Ensign Peak Advisors’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,080
Closed -$173K 2223
2022
Q1
$173K Hold
30,080
﹤0.01% 1918
2021
Q4
$451K Buy
30,080
+8,980
+43% +$164K ﹤0.01% 1665
2021
Q3
$553K Hold
21,100
﹤0.01% 1603
2021
Q2
$1.05M Hold
21,100
﹤0.01% 1420
2021
Q1
$972K Hold
21,100
﹤0.01% 1437
2020
Q4
$904K Hold
21,100
﹤0.01% 1435
2020
Q3
$860K Hold
21,100
﹤0.01% 1367
2020
Q2
$1.16M Hold
21,100
﹤0.01% 1226
2020
Q1
$1.1M Hold
21,100
﹤0.01% 1129
2019
Q4
$1.03M Buy
+21,100
New +$988K ﹤0.01% 1328

Other funds holding TRHC

Ensign Peak Advisors's TRHC Position: Q2 2022 in Review

Ensign Peak Advisors sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 30,080 shares — an estimated $173K sold.

Ensign Peak Advisors first reported a position in TRHC in Q4 2019 and held it in 10 quarters. The position peaked at $1.16M in Q2 2020. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • Ensign Peak Advisors reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 30,080 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $173K.
  • Ensign Peak Advisors first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Ensign Peak Advisors's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $1.16M in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.